In a pro and con debate, Prof. Piet Ost and Prof. Betrand Tombal discussed the potential of metastasisdirected therapy for patients with oligorecurrent prostate cancer.
In a pro and con debate, Prof. Piet Ost and Prof. Betrand Tombal discussed the potential of metastasisdirected therapy for patients with oligorecurrent prostate cancer.
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
